A RECENT inhalation study has demonstrated that hexamethylphosphoramide (HMPA) (I in Fig. 1 ) is a powerful rodent carcinogen (Zapp, 1975; Lee et al., 1978) . Since this property had not previously been associated with phosphoric amides, it became of interest to investigate how general this effect was among compounds structurally related to HMPA. In order to study chemical structure/biological activity relationships without initially undertaking further long-term animal tests, use must be made of an in vitro carcinogenicity assay. In an earlier paper we described an evaluation of HMPA and several of its structural analogues in 2 such in vitro assays. The conclusions reached at that time were as follows:
(1) Of the in vitro tests available to us, the cell transformation assay of Styles (1977) was best suited to studying this class of potential carcinogen. (2) That any further in vitro studies with analogues of HMPA should be conducted in the presence of the appropriate positive and negative chemical class controls, HMPA (I) and phosphoric trianilide (II) respectively. (3) That the broad structural requirements for carcinogenicity observed for the nitrosamine carcinogens (an example of which is dimethylnitrosamine, DMN (III) ; Druckrey 1975) miight also apply to this new class of phosphoramide carcinogens. The present paper describes experiments designed to evaluate a prediction we made in our previous paper based upon point (3) above, namely, that compounds such as trimorpholinophosphine oxide (IV) would possess carcinogenic potential due to their structural relationship to the putatively analogous carcinogen nitrosomorpholine (V). The additional compounds synthesized and tested for this purpose were hexamethylphosphorous triamide (VI), hexamethylphosphorothioic triamide (VII), tripiperidinophosphine oxide (VIII), phosphorothioic trimorpholide (IX) and diethoxymorpholinophosphine oxide (DEMPA, X). Each has been evaluated in the cell trans- formation assay of Styles, under 2 different conditions of metabolic activation.
MATERIALS AND METHODS
Chemicals8.-N.M.R. spectra were recorded at 60 MHz on a Perkin-Elmer R-12 and at 100 MHz on a Varian HA lOOA or HA lOOD instrument, and were consistent with the required structures. Micro-analytical data for C, H and N were within 0400 of the theoretical values.
Hexamethylphosphoric triamide (I) and phosphoric trianilide (II) have been described by us previously , and the same batches of material were used in the present study.
Hexamethylphosphorous triamide (VI) was purchased from Aldrich Chemical Company Ltd, Gillingham, Dorset and was redistilled to give a clear colourless liquid b.p. 52-53°/16 mm (Burgada, 1963, records b.p. 51°/15 mm) .
Hexamethylphosphorothioic triamide (VII) was prepared by reaction of hexamethylphosphoric triamide (I) with sulphur and purified according to the method described by Vetter & Noth (1963) . The appropriate distillation fraction was redistilled to give the product, b.p. 65-65-5°/1 mm (Vetter & Noth, 1963, report b.p freshly distilled piperidine (128 g 1-5 mol) in petroleum ether b.p. 60-800 (250 ml) keeping the temperature below 25°C by cooling in an ice bath. After stirring overnight at laboratory temperature, the reaction mixture was filtered to remove piperidine hydrochloride which was washed with petroleum ether. The combined filtrate was evaporated and the residual yellow oil distilled collecting the white oily semi-solid b.p. 185-190°/1 mm. This material contained some piperidine hydrochloride which had sublimed simultaneously, therefore, the semi-solid mass was extracted with petroleum ether (150 ml) and filtered. Evaporation of the filtrate gave 39-3 g (58-70%) of a clear, pale, yellow oil which slowly crystallized to give the product as colourless needles (after being scratched with a glass rod). The pure product was extremely hydroscopic and analysed as a hemihydrate.
Phosphorothioic trimorpholide (IX) was provided by ICI Organics Division and purified by recrystallisation from isopropanol as large colourless needles m.p. 145-5-1460 (Audrieth & Toy, 1942 Poole, Dorset) was prepared just prior to testing. Cell Transformation Assay.-The methods employed when testing a compound for potential carcinogenicity using growth of mammalian cells in semi-solid have been described in detail (Styles, 1977) . The cells used in this study were two distinct sub-clones of BHK 21/C13, the first of which had a spontaneous transformation frequency of 50/106 survivors whilst the later clone, which is now being used routinely, had a spontaneous transformation frequency of 10/106 survivors. In all experiments with both sub-clones, a positive result was recorded when the transformation frequency/106 survivors at the LD50 dose-level exceeded 5x the control frequency/106 survivors. Thus, with the earlier clone, the threshold frequency for a positive response was 250 transformations/106 survivors, and with the later clone 50 transformations/106 survivors. This difference is seen as a change in the position of the horizontal dotted line in Figure 2 . All experiments were conducted in the presence of the appropriate chemical class positive and negative controls (Ashby & Purchase, 1977) , namely, HMPA (I) and the trianilide (II) respectively.
Rat liver homogenate (S-9 mix).-The S-9 fraction was prepared from Aroclor 1254 induced rats, as previously described (Styles, 1977) . The S-9 fraction was then combined with co-factors to give the S-9 mix. In the present experiments two separate protocols for preparing and using the S-9 mix were used. The first was the same as we have previously employed with this assay (Styles, 1977; , i.e. 10 p1 per incubation tube of a mix consisting of S-9 fraction and co-factors in the ratio 1:9. The second involved adding 50 yd per incubation tube of a mix consisting of S-9 fraction and co-factors in the ratio 1: 1.
RESULTS
Four separate experiments were conducted on the complete set of test compounds (see below). Duplicate plates were used at each dose level with each compound, DMSO acting as the test negative control. A tabulation of the 4 experiments conducted is shown in the Table. Experiment 2 is a repeat of Experiment 1 and both were conducted using the standard S-9 mix (1:9, 10 l l). Experiment 4 is a repeat of Experiment 3 and both were conducted using the modified S-9 mix (1:1, 50 Figure  2 . Those figures representing data generated using the modified S-9 mix (50 1A 1: 1) are indicated by an asterisk close to the chemical structure. Figure 2 shows the response given by HMPA (I) [as an average of 6 separate experiments (spaced over 2 years) using the earlier clone and standard S-9 mix (Fig. 2a) , as tested using standard S-9 mix but using the new clone (Fig. 2b) , and as in the present experiments ( Fig. 2c & d) ], hexamethylphosphorous triamide (VI) (Fig. 2e & f) , hexamethylphosphorothioic triamide (VII) (Fig. 2g &  h) , the morpholine derivative IX (Fig. 2i Fig. 2a & b) Concentration pg /ml and in both series, derivatives which lack a free alpha-position, such as diphenylnitrosamine (XI) and phosphoric trianilide (II), are inactive in vitro as cell transforming agents and as bacterial mutagens . The advantage to be gained by establishing some form of analogy between these 2 classes of carcinogens is that a lot is known about the structural pre-requisites for carcinogenicity within the nitrosamine class (Druckrey, 1975) E cribed earlier contribute to a more accurate definition of this putative link. It would be anticipated that the S-9 mix would be capable of oxidizing the phosphorous atom of hexamethylphosphorous amide (VI) thereby generating HMPA (I) in vitro. Assuming that the oxidative capacity of the S-9 mix approximates to that in vivo, the positive assay response produced by VI probably indicates that the presence or absence of the P-=O oxygen group in a derivative of HMPA is not of major importance when assessing that compound's potential for causing cancer.
Likewise, we anticipated that the S-9 mix would convert the thio (=S) group of hexamethylphorothioic triamide (VII) into an oxo (z O) group, therebv yielding IIMPA in vitro, and that this compound would thereby give a positive assay response. The fact that this was realized only when using the modified S-9 mix may be due to inactivation of the standard S-9 mix by sulphur radicals generated during the thione hydrolysis process (De Matteis, 1977) . The modified activation system had a greater quantity of S-9 fraction per incubation tube (5.8 mg/ml as opposed to 0245 mg/ml of total test medium) which may have allowed any destructive effects produced on the standard activation system to be absorbed, leaving a competent metabolic system capable of activating the derived HMPA. Therefore, the positive effects observed for HMPA (I), its deoxyderivative (VI) and its thio-derivative (VII) indicate that the groups P_O, P and P S should be regarded as equivalent (in particular to P O) when new derivatives of HMPA are to be selected as candidates for in vitro evaluation. The three alicyclic ring analogues of HMPA, compounds IX, VIII and X, were each negative when tested using the standard S-9 mix, and each was relatively nontoxic to the cells. However, when the modified S-9 mix was employed, cell toxicity increased dramatically and positive transformation effects were observed in each case. A similar effect was observed following modifications made to the chemical structure of a series of thiophene derivatives . In that case the overall metabolism of the compounds was influenced by chemical features, whilst in the present experiments similar changes have arisen following changes made to the S-9 mix. The above 3 phosphoramide derivatives have, therefore, been defined as both reproducibly positive and reproducibly negative dependent upon the conditions of in vitro activation. In both circumstances the appropriate chemical class control substances were correctly identified. Were either of these controls to have changed their test response with the change in S-9 mix, serious doubts about the likely in vivo significance of the above three reversible positive results could have been raised. As it has been demonstrated that the change made to the cell clone (altered frequency of spontaneous transformation) could not have produced these changed responses, the change in S-9 mix must have been responsible.
A possible explanation for these effects is that one or more of the critical steps in the activation of these 3 compounds is more sensitive to the constitution of the activation system, or to the physicochemical environment of activation, than are the corresponding steps in the activation of HMPA, although even in that case the transformation frequency is marginally increased when using the modified S-9 mix (Fig. 2d) . It could, therefore, be inferred that whilst these 3 compounds have been defined as potential carcinogens, the range of metabolic circumstances under which this potential will be expressed may be more limited than in the case of HMPA. If it could be shown that either one of the activation systems used was more relevant than the other to the situation in vivo, then firm predictions of the likely carcinogenic potential of these compounds could be made. This is not possible, in fact it is likely that both of these separate metabolic conditions, together with many others, will occur in vivo, if only transiently or locally in some tissues. The use of appropriate chemical class controls, therefore, contri-buted to an interpretation of the experimental data and may have helped to define some limiting aspects of the potential carcinogenicity of compounds IX, VIII and X.
It has already been demonstrated that changes made to the quantity of S-9 mix added to the incubation medium of an in vitro assay, or changes made to the S-9 fraction:co-factor ratio can modulate the in vitro response given by a chemical (Ames et al., 1973; . The present example represents the extreme case of passing from inactivity to activity in vitro following such changes. Whilst it could, therefore, be argued that all in vitro evaluations of new chemicals should be carried out using a wide range of S-9 mixes, this may be unnecessarily extreme. Rather, it may be necessary only to evaluate compounds using a small, but widely separated range of S-9 mixes in cases where an initially derived negative response is not compatible with what is already known about, or expected from, an individual chemical or class of chemicals. We have discussed elsewhere the wider implications raised by such changes to an observed in vitro response induced by changes made to the S-9 mix Ashby & Styles 1978a, b) .
It therefore seems likely that a family of specifically substituted phosphoramides, rather than only HMPA itself, may have carcinogenic potential. Further, a unifying thread may connect this new class of potential carcinogens with the well established class of nitrosamine carcinogens.
As a result it is suggested that the structural criteria established for the latter class of carcinogens may be of help in delineating the most likely potential carcinogens within the phosphoramide class.
Hexamethylphosphoramide is an extremely potent carcinogen for rats, exposure to 0-02/106 in air producing positive effects. It is, therefore, tempting to assume that any new carcinogens of this class will also be abnormally potent, but this idea should be approached with caution. The tumours produced by HMPA originated in the nasal region, during an inhalation study, and this may represent preferrential access and concentration of this unusual solvent in the membranes surrounding the convoluted turbinate bones of rats. Not only is this bone structure unrepresentative of man, but any solid derivatives of HMPA (such as VIII and IX) would be evaluated for carcinogenicity via the oral route, and would, therefore, be unlikely to present this problem. These compounds might well be carcinogenic, but they may possess a much lower potency than HMPA and a different target organ specificity.
There remains one apparent inconsistency with this chemical class analogy; that is, that after alpha-hydroxylation and formaldehyde release, dimethylnitrosamine (III) generates methyldiazonium hydroxide (XII), an active alkylating species (and one which is the assumed effective mutagen and carcinogenic initiator). After a similar sequence of biochemical changes had taken place with HMPA, pentamethylphosphoramide (XIII) would be formed, a compound not expected to possess alkylating properties. This could indicate that the reaction mechanism proposed for the activation of nitrosamine carcinogens (Druckrey, 1975 ) is only one of several possible mechanisms, another of which might also be consistent with the activation of HMPA as a mutagen and carcinogen. Consideration of these possible mechanisms will be discussed elsewhere.
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